FDA Warns Tofacitinib (XELJANZ, XELJANZ XR) Increases Risk of Serious Heart-Related Adverse Effects and Cancer

Worst Pills, Best Pills

An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

Print Friendly

All E-Alerts

E-Alerts

FDA Warns of Alcohol Intolerance, Seizures With Varenicline (CHANTIX) (March 11, 2015)
New Warnings on an Alzheimer’s Drug (February 5, 2015)
Fake IV fluids used at clinics (January 15, 2015)
Serious Skin Reactions With Alzheimer’s Treatment (December 4, 2014)
New Warnings for Prolia (July 16, 2014)
Severe Allergic Reactions to Acne Treatments (July 2, 2014)
Do Not Use Eszopiclone (LUNESTA) At Any Dose (May 19, 2014)
New Warnings About Heart Rhythm Problems with the Antidepressant Drug Mirtazapine (May 5, 2014)
Do Not Use Steroid Injections for Back Pain (April 29, 2014)
Liver Injury Risks with Acetaminophen Products (February 3, 2014)

3 of 10

The information on this website is not intended to substitute for professional medical advice, diagnosis, or treatment. Consult your doctor before changing or discontinuing any medication.

All E-Alerts

Site Links

Subscriptions

Disclaimer